Asiri A, Al Qarni A, Bakillah A
Diagnostics (Basel). 2024; 14(19).
PMID: 39410536
PMC: 11475808.
DOI: 10.3390/diagnostics14192132.
Lee H, Hah Y, Cheon S, Won S, Yim C, Ryu S
Eur Thyroid J. 2024; 13(5).
PMID: 39121020
PMC: 11466257.
DOI: 10.1530/ETJ-24-0079.
Zhang C, Xu A, Liu R, Liu M, Zhao W, Yao A
Heliyon. 2024; 10(12):e32245.
PMID: 38975094
PMC: 11226785.
DOI: 10.1016/j.heliyon.2024.e32245.
Szymanski M, Bonowicz K, Antosik P, Jerka D, Glowacka M, Soroka M
Cancers (Basel). 2024; 16(4).
PMID: 38398227
PMC: 10886501.
DOI: 10.3390/cancers16040836.
Du L, Liu N, Jin J, Cao M, Sun Y, Gao X
Acta Biochim Biophys Sin (Shanghai). 2023; 54(12):1889-1896.
PMID: 36789689
PMC: 10157515.
DOI: 10.3724/abbs.2022187.
Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer.
Xu Y, Wu Q, Tang Z, Tan Z, Pu D, Tan W
J Pers Med. 2023; 13(1).
PMID: 36675706
PMC: 9863352.
DOI: 10.3390/jpm13010044.
Overexpression of Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity.
Kim C, Lee H, Nam M, Choi Y, Choi K
Mol Cells. 2022; 45(12):935-949.
PMID: 36572562
PMC: 9794555.
DOI: 10.14348/molcells.2022.0105.
Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway.
Jin Q, Chen Y, Du S, Xu D, Yue J, Cai L
Curr Cancer Drug Targets. 2022; 22(11):919-930.
PMID: 35909289
PMC: 9900700.
DOI: 10.2174/1568009622666220728123748.
Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.
Zhang Y, Ma P, Duan Z, Liu Y, Mi Y, Fan D
Int J Mol Sci. 2022; 23(4).
PMID: 35216134
PMC: 8879721.
DOI: 10.3390/ijms23042018.
G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer.
Jin Y, Park S, Park S, Lee C, Eum D, Shim J
Int J Mol Sci. 2022; 23(2).
PMID: 35054776
PMC: 8776044.
DOI: 10.3390/ijms23020589.
Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-cadherin and ß-catenin in Grades of Oral Squamous Cell Carcinoma.
Kumar V, Panda A, Dash K, Bhuyan L, Mahapatra N, Mishra P
J Pharm Bioallied Sci. 2021; 13(Suppl 1):S555-S560.
PMID: 34447152
PMC: 8375807.
DOI: 10.4103/jpbs.JPBS_562_20.
3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis.
Munakarmi S, Shrestha J, Shin H, Lee G, Jeong Y
Cells. 2021; 10(5).
PMID: 34066056
PMC: 8151225.
DOI: 10.3390/cells10051178.
Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells.
Kim H, Lee J
Oncol Lett. 2021; 21(2):155.
PMID: 33552273
PMC: 7798102.
DOI: 10.3892/ol.2020.12416.
Nrf2 regulates cell motility through RhoA-ROCK1 signalling in non-small-cell lung cancer cells.
Ko E, Kim D, Min D, Kwon S, Lee J
Sci Rep. 2021; 11(1):1247.
PMID: 33441941
PMC: 7806835.
DOI: 10.1038/s41598-021-81021-0.
DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells.
Wang S, Huang K, Tseng W, Lo J, Li A, Fang W
Cancers (Basel). 2020; 12(11).
PMID: 33233689
PMC: 7699785.
DOI: 10.3390/cancers12113463.
C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells.
Ji H, Liu G, Han J, Zhu F, Dong X, Li B
Cancer Cell Int. 2020; 20:292.
PMID: 32655324
PMC: 7339474.
DOI: 10.1186/s12935-020-01384-8.
Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
Fu X, Liu B, Wang Y, Li J, Zhu P, Li T
Cell Death Dis. 2020; 11(4):246.
PMID: 32312954
PMC: 7171093.
DOI: 10.1038/s41419-020-2440-1.
Depletion of CDC5L inhibits bladder cancer tumorigenesis.
Zhang Z, Mao W, Wang L, Liu M, Zhang W, Wu Y
J Cancer. 2020; 11(2):353-363.
PMID: 31897231
PMC: 6930429.
DOI: 10.7150/jca.32850.
COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X, Qu P, Zhao H, Zhao T, Cao N
Mol Med Rep. 2019; 20(4):3811-3819.
PMID: 31485669
PMC: 6755176.
DOI: 10.3892/mmr.2019.10598.
BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
Zhu L, Pan R, Zhou D, Ye G, Tan W
Cancer Manag Res. 2019; 11:2997-3007.
PMID: 31114347
PMC: 6489585.
DOI: 10.2147/CMAR.S199368.